We would like to introduce you to the SHS portfolio companies in a new series. We start with SIS Medical AG, a leading Swiss manufacturer of balloon catheters for interventional dillatation of the coronary vessels. Dr Sergej Kammerzell has been CEO at SIS for two years; he is a human physician and holds a doctorate […]

This year we once again hosted the annual Investors’ Day and the shareholders’ meetings of the SHS Funds. To our great pleasure, it was again possible this year to hold the event in the presence of the investors. Investors, portfolio representatives, our senior advisors and healthcare experts were invited to the Hotel Krone in the […]

Digital health applications (DiGA) can improve medical care.

Before joining SHS, Lukas worked as a manager at one of the Big Four auditing firms in southern Germany. He completed his Bachelor of Science in Business Administration with a focus on Corporate Accounting and Finance at the LMU in Munich. He completed his Master’s degree at the University of Mannheim with a focus on […]

The fast-growing Norwegian healthcare provider Dropin enables short-term medical consultation and treatment – in person on site as well as digitally via app Dropin posted revenue of more than 30m EUR in 2021, constituting a CAGR of more than 100% for the last three years SHS invests from its fifth fund generation in the Scandinavian […]

The fast-growing MedTech company phenox specialises in instruments and implants for the neurointerventional therapy of stroke With the growth capital provided by SHS et al., the Bochum-based company has developed from a start-up into a global leader in the field of stroke therapy A successful exit for investors from the third SHS fund generation The […]

With the Corona pandemic, the healthcare sector, among others, has become the focus of increased attention among investors. SHS in Tübingen, an investment company specialising in the healthcare sector, outlines the asset classes that can be used to track such stocks.  

The healthcare sector has come under increased public scrutiny as a result of the Corona pandemic. M&A deals in the sector have reached a high level in 2021. Many lighthouse companies, however, choose the US market for the participation of an investor or the IPO. Funders like SHS Gesellschaft für Beteiligungsmanagement mbH also offer companies […]

Today, anyone who has to endure painful dental treatment asks their dentist for an injection as a matter of course. But in the case of a first operation with general anaesthesia, many patients probably ask themselves whether they will really not notice anything of the operation and the pain – despite comprehensive information from the […]

SHS is pleased to be able to offer students the opportunity for practical experience within the framework of an internship in 2022 and to provide them with an insight into the private equity sector. We have been pleased to welcome Charlotte Eusterbrock to SHS since mid-November 2021. Charlotte is currently completing her Bachelor’s degree in […]

As part of a strategic partnership, the German healthcare company AMW will in future focus on the development, approval and licensing of biodegradable transdermal delivery systems. The new French partner AdhexPharma is responsible for series production and lifecycle management and brings with it the best prerequisites for this. “We are pleased that our portfolio company […]

Mitral valve regurgitation (leakage) is one of the very common heart diseases. It is estimated that around 25 million patients worldwide suffer from it. CoreMedic GmbH has developed the ChordArt™ mitral valve repair system, a device for the safe repair of the mitral valve. In a broad, two-year patient study, the ChordArt™ system has now […]